docetaxel anhydrous and adenosine
docetaxel anhydrous has been researched along with adenosine in 4 studies
Compound Research Comparison
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 32,536 | 1,075 | 8,930 |
Protein Interaction Comparison
Protein | Taxonomy | docetaxel anhydrous (IC50) | adenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jeengar, MK; Khan, W; Naidu, VG; Singh, I; Sistla, R; Swami, R | 1 |
Li, H; Li, X; Lv, M; Qiao, B | 1 |
Gu, HY; Hu, C; Huang, ZD; Lin, LL; Liu, ZZ; Wei, RX | 1 |
Reviews
1 review(s) available for docetaxel anhydrous and adenosine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
3 other study(ies) available for docetaxel anhydrous and adenosine
Article | Year |
---|---|
Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Docetaxel; Humans; Lipids; Mice; Nanoparticles; Neoplasms; Taxoids | 2015 |
Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer.
Topics: Adenosine; Animals; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Disease Models, Animal; Docetaxel; Female; Humans; Mice; Tetraspanins | 2019 |
m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
Topics: Adenosine; Antineoplastic Agents; Deoxycytidine; DNA Copy Number Variations; DNA Methylation; Docetaxel; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Kaplan-Meier Estimate; Sarcoma | 2021 |